Is a Developmental Venous Anomaly Dangerous?

Developmental Venous Anomalies (DVAs) are common, low-pressure venous variations. Understand their function, benign nature, and associated risks.

A developmental venous anomaly, or DVA, is overwhelmingly benign. It is the most common vascular anomaly found in the brain, and the vast majority are discovered by accident on brain scans ordered for unrelated reasons. A large systematic review found that in population-based follow-up, there were zero symptomatic hemorrhages or infarcts over nearly 500 person-years of observation. That said, learning you have one can be unnerving, and there are real, if uncommon, scenarios where a DVA does matter clinically.

What a DVA Actually Is

A DVA is not a tumor, not a ticking time bomb, and not really a “malformation” in the way most people think of that word. It is better understood as an unusual but functional variation in how veins drain blood from a region of the brain. During early fetal development, veins in the brain go through a process of remodeling. If something disrupts that process in the late first trimester, the normal small veins in a patch of brain tissue fail to mature in the usual way. Instead, a cluster of tiny veins converges on a single enlarged collector vein that carries blood to a larger sinus or deep vein.

On an MRI with contrast, this cluster of small veins fanning out toward a central collector has a distinctive starburst or spoke-wheel pattern sometimes called “caput medusae,” after the snake-haired figure from Greek mythology. The appearance is so characteristic that contrast-enhanced MRI alone is usually enough to make the diagnosis without additional testing.

The key point is that a DVA is the only venous drainage route for the surrounding brain tissue. The normal veins that would have served that area never developed. The DVA is doing the job, just in an architecturally unusual way. This fact has enormous consequences for treatment decisions, as we will see.

How Often They Are Found and What Typically Happens

DVAs show up frequently on brain imaging. Most people who have one never know it exists until a scan is done for headaches, dizziness, or something else entirely. In a systematic review pooling data from 15 studies covering over 700 people, about 61% of DVAs were incidental findings. Only about 6% had caused a symptomatic bleed, 6% presented with a neurological deficit unrelated to hemorrhage, and 4% were associated with a seizure. When the same review looked at a carefully followed population-based group of 93 adults with DVAs, 98% were incidental, and over nearly 500 person-years of follow-up, not a single symptomatic hemorrhage or infarct occurred.

These numbers are reassuring and consistent with how neurologists and neurosurgeons generally treat DVAs: if you have one and it was found by accident, the standard approach is to leave it alone. No surgery, no medication, and usually no ongoing surveillance imaging is needed for an isolated, uncomplicated DVA.

When a DVA Does Cause Trouble

Although the odds of a DVA causing symptoms on its own are low, it does happen. The complications fall into a few categories, and almost all of them are rare.

Hemorrhage from a DVA alone is genuinely uncommon. When bleeding does occur near a DVA, the culprit is usually a different lesion sitting alongside it, most often a cavernous malformation. In one single-center series of 101 patients, 22 presented with hemorrhage, but only 10 of those had a DVA alone; the rest had an accompanying lesion such as a cavernoma or arteriovenous malformation. So even in a study that specifically set out to identify problematic DVAs, most of the bleeding events had another explanation.

Thrombosis of the collector vein is another rare but recognized complication. Because the DVA is the sole drainage pathway for its territory, if a clot forms inside it, the surrounding brain tissue can become congested. This can lead to venous infarction, swelling, and sometimes hemorrhage. Case reports describe patients presenting with sudden neurological symptoms such as cerebellar ataxia after spontaneous thrombosis of a DVA’s collector vein. Thrombosis is serious when it happens, but it remains an uncommon event across a person’s lifetime.

Seizures linked to an isolated DVA are also unusual. When seizures occur in someone with a DVA, careful imaging typically reveals an associated lesion like a cavernoma or a patch of cortical dysplasia that better explains the seizure. It remains rare and uncertain that an uncomplicated, isolated DVA causes seizures on its own.

The Cavernous Malformation Connection

If there is one thing that elevates the clinical significance of a DVA, it is the relationship with cavernous malformations, also called cavernomas. These are clusters of abnormal, thin-walled blood vessels that can bleed. DVAs and cavernomas are frequently found together, and this association is not coincidental.

Research has shown that the chronic low-grade venous congestion created by a DVA can encourage the formation of cavernomas over time. The DVA essentially acts as a breeding ground. Genetic studies have demonstrated that when a DVA and a cavernoma co-exist, the DVA carries an earlier somatic mutation in a gene called PIK3CA, and the cavernoma that develops later acquires an additional mutation, suggesting the cavernoma literally grows out of the DVA’s abnormal vascular bed. In other words, the DVA comes first, and the cavernoma is a secondary event.

This matters because cavernomas can bleed, and they carry a meaningfully higher hemorrhage risk than a DVA alone. However, the picture is nuanced. One large study of over 700 patients with cavernomas found that the mere presence of a DVA alongside the cavernoma did not independently predict future hemorrhage; what mattered more was whether the patient had already bled and whether the cavernoma was located in the brainstem. A more recent study, though, found that certain patterns of venous architecture around a sporadic cavernoma with a DVA were associated with substantially different hemorrhage rates, with the highest-risk group experiencing bleeds roughly four times more often than the lowest-risk group.

The takeaway for someone with both a DVA and a cavernoma is that the cavernoma is the lesion your neurologist will be watching more carefully. If you have a DVA without a cavernoma, the risk profile is much lower, though there is a small chance one could develop over time. For patients with both lesions, regular monitoring of symptoms and periodic imaging are generally recommended, with surgery reserved for cases with significant or repeated bleeding or worsening neurological deficits.

Why Surgery on a DVA Is Almost Never Done

One of the most important things to understand about a DVA is that removing it or blocking it off is dangerous. Because the DVA serves as the only venous outflow for its patch of brain, cutting it off would strand that tissue without drainage. The result would be venous infarction, essentially a stroke caused by backed-up blood. Both surgical removal and catheter-based occlusion carry this risk, and the medical literature is consistent that obliteration of a DVA should be avoided.

This means that even in the uncommon situation where a DVA is causing problems, the DVA itself is generally left intact. If a cavernoma next to the DVA needs to be surgically removed because of repeated hemorrhage, the neurosurgeon will carefully excise the cavernoma while meticulously preserving the DVA’s collector vein. Similarly, if an arteriovenous fistula is found draining through a DVA, it may be possible to treat the fistula while keeping the DVA functional. The guiding principle is always the same: the DVA is doing necessary work, and harming it creates a bigger problem than the DVA itself ever posed.

Subtle Effects on Surrounding Brain Tissue

Even when a DVA causes no obvious symptoms, imaging sometimes reveals changes in the brain tissue around it. White matter lesions, mild tissue shrinkage, and small calcifications in the DVA’s drainage territory are not unusual findings on MRI. These changes are thought to result from chronic, low-grade venous congestion: blood draining through the DVA encounters slightly higher pressure than it would through a normal venous network, and over years this can leave its mark on nearby tissue. Perfusion-weighted imaging, which maps blood flow patterns, supports this picture by showing areas of hemodynamic congestion around DVAs even when the person has no symptoms.

A recent case report pushed this idea further using FDG PET, a type of scan that measures how actively brain cells are using energy. In a 63-year-old man with mild cognitive decline, the PET scan showed reduced metabolic activity not just at the DVA itself but spreading into surrounding tissue that looked perfectly normal on standard MRI. This is a single case and should not be overgeneralized, but it raises the possibility that DVAs may exert a wider functional footprint than structural imaging alone can detect.

For most people, these subtle tissue changes never translate into noticeable symptoms. The brain has enormous functional reserve, and mild venous congestion in one small territory is usually something it accommodates without trouble. But the findings are a reminder that calling a DVA completely inert oversimplifies the biology.

DVAs in Children

DVAs are present from early development, so they exist in children too. In the pediatric population, they are the most common brain vascular malformation identified on imaging and are generally treated with the same reassuring outlook as in adults. The hemorrhage risk is similarly estimated at less than 1% per year, and seizures or neurological deficits, while occasionally reported in pediatric patients, remain uncommon.

One area of active interest in pediatric DVA research involves newer physiological imaging techniques. Standard MRI can show the structure of the DVA, but advanced tools like perfusion imaging and susceptibility-weighted imaging can reveal whether the tissue around the DVA is experiencing subtle drainage problems. Pediatric radiologists have noted that the venous drainage through a DVA appears to have less physiological flexibility than normal venous drainage, meaning it may be less able to adapt to changes in blood flow or pressure. Whether this translates into any meaningful long-term consequences for most children is unknown. The standard clinical approach remains observation without intervention unless a child develops symptoms or an associated lesion like a cavernoma is identified.

Pregnancy and Thrombosis Risk

There is no established consensus on whether pregnancy increases the risk of DVA-related complications, but the question has come up in case reports. Pregnancy involves significant shifts in blood volume, clotting factors, and venous pressure, all of which could theoretically stress an already unusual venous drainage pathway.

In one reported case, a woman at 8 weeks of pregnancy who was severely dehydrated from hyperemesis gravidarum developed a clot in the collector vein of a frontal DVA, leading to a small hemorrhage and seizure. Her doctors suspected the severe dehydration contributed to the clot formation. This is a single anecdote and not evidence that pregnancy is broadly risky for people with DVAs. Most women with an incidental DVA will go through pregnancy without any related issues. But if you have a known DVA and are pregnant or planning to be, it is reasonable to mention it to your obstetrician so they have the full picture, particularly if you develop conditions that promote dehydration or clotting.

The Genetics Behind DVA Formation

For a long time, DVAs were considered simple plumbing accidents with no particular genetic signature. That understanding has shifted. Research has identified somatic mutations, meaning genetic changes that arise in a small number of cells during development rather than being inherited, in the tissue of DVAs themselves. The gene PIK3CA, which plays a role in cell growth and blood vessel formation, has been found mutated in DVA tissue. When a cavernoma develops alongside a DVA, the cavernoma carries the same PIK3CA mutation plus an additional hit in another gene, MAP3K3. The DVA has the first mutation; the cavernoma has both. This two-hit pattern mirrors what happens in some types of tumor development, where one mutation sets the stage and a second mutation drives a more abnormal growth.

Separately, a case of a child with multiple DVAs and cutaneous vascular malformations revealed a germline mutation in EPHB4 alongside a somatic PIK3CA mutation, suggesting that in rare cases, an inherited vulnerability in vascular signaling genes may predispose someone to developing DVAs in the first place. This kind of genetic overlap between DVAs, cavernomas, and other vascular malformations has led some researchers to propose that these lesions may all sit on a spectrum of the same underlying vascular disease rather than being entirely separate entities.

This genetic work is still in its early stages and does not change management for most patients today. But it is starting to explain why some DVAs stay quiet for a lifetime while others eventually develop an associated cavernoma. If the field advances to the point where genetic profiling of vascular lesions becomes practical, it could one day help identify the small subset of DVAs that warrant closer monitoring.